Akums Drugs and Pharmaceuticals Limited is an India-based pharmaceutical contract development and manufacturing company. The Company offers a comprehensive range of pharmaceutical products and services in India and overseas. The Company’s segments include Contract Development and Manufacturing Operations (CDMO), Active Pharmaceutical Ingredient (API), Domestic Branded Formulations, International Branded Formulations, and Trade Generics. The CDMO segment is engaged in formulation research and development, preparation and regulatory filing of dossiers, manufacturing formulations on a contract basis, job work and testing services. The API segment is engaged in the manufacture and sale of key starting materials, Intermediate and API products. The Domestic Branded Formulations segment includes marketing of its branded formulations in the Indian market. The International Branded Formulations segment undertakes the marketing of its branded formulations in the global market. As of 25 May 2026, AKUMS DRUGS AND PHARMA L share price is ₹521.00. The stock opened at ₹530.00, compared to its previous close of ₹520.05. During today's trading session, AKUMS DRUGS AND PHARMA L share price moved in the range of ₹514.90 to ₹531.85, with an average price of ₹523.38 for the day. Looking at its last 52-week, the stock has touched a low of ₹514.90 and a high of ₹531.85.
The market capitalization of AKUMS DRUGS AND PHARMA L is ₹8,190 Crs, with a P/E ratio of 31.9 and a dividend yield of 0.56%.